In this episode of the EADV Podcast, host Dr. Sarah Walsh sits down with Prof. Thrasivoulos Tzellos during the 2025 EADV Spring Symposium in Prague to discuss the latest European guidelines for the treatment of hidradenitis suppurativa (HS).
Together, they explore the evolution of HS care, the role of general practitioners in early detection, the value of clinical tools and patient-reported outcomes, and the potential of emerging therapies. Prof. Tzellos also shares his thoughts on antimicrobial resistance, phenotype-based treatment, and the importance of multidisciplinary care. The conversation is grounded in both evidence-based recommendations and real-world clinical experience, with reflections on how advocacy and access to care remain vital components of improving outcomes for HS patients across Europe.
Tune in to discover practical insights and the latest developments that are shaping the future of HS treatment.
Your feedback is valued and appreciated to allow us to better serve our audience
